| Current Price | $109.13 | Mkt Cap | $10.4B |
|---|---|---|---|
| Open | $108.67 | P/E Ratio | 177.70 |
| Prev. Close | $108.38 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $108.43 - $109.52 | Volume | 119,841 |
| 52-Wk Range | $72.28 - $129.29 | Avg. Daily Vol. | 773,803 |
Discovers, develops and intend to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Product candidates will target insomnia, anxiety, depression, cancer, diabetes, and multiple sclerosis.
| Current Price | $109.13 | Mkt Cap | $10.4B |
|---|---|---|---|
| Open | $108.67 | P/E Ratio | 177.70 |
| Prev. Close | $108.38 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $108.43 - $109.52 | Volume | 119,841 |
| 52-Wk Range | $72.28 - $129.29 | Avg. Daily Vol. | 773,803 |
The best Bull and Bear pitches based on recency and number of recommendations.
The company expects to expand the label for its lead therapy, Ingrezza, used to treat movement disorders. With that, should come expanded profits.
Neurocrine has been turning in solid pipeline progress for several years now but they haven't had much success holding gains in the share price. Now that the phase III trial of elagolix is in progress I expect at least a year before all 875 patients… More
Read the most recent pitches from players about NBIX.
Recs
mrbill6
(59.00)
Submitted: 1/16/2023 4:45:55 PM :
Start Price:
$109.16
NASDAQ:NBIX Score:
-1.95
POWR A
Recs
TMFjimhalley
(21.46)
Submitted: 9/1/2022 4:26:13 PM :
Start Price:
$105.55
NASDAQ:NBIX Score:
+1.92
The company expects to expand the label for its lead therapy, Ingrezza, used to treat movement disorders. With that, should come expanded profits.
Recs
TMFSecurity
(91.93)
Submitted: 11/16/2021 9:14:14 AM :
Start Price:
$87.86
NASDAQ:NBIX Score:
-37.21
10000000146
Find the members with the highest scoring picks in NBIX.
gsm1999 (50.17) Score: +4,383.28
The Score Leader is the player with the highest score across all their picks in NBIX.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| gsm1999 | 50.17 | 3/8/2010 |
|
5Y | $2.30 | +4,638.26% | +254.98% | +4,383.28 | 0 Comment | |
| awsumrocker | 89.22 | 3/10/2010 |
|
3M | $2.35 | +4,537.45% | +254.20% | +4,283.24 | 0 Comment | |
| stockamuteur | 44.10 | 4/8/2010 |
|
5Y | $2.57 | +4,140.47% | +243.87% | +3,896.59 | 0 Comment | |
| Tadpole85 | 74.99 | 1/5/2010 |
|
1Y | $2.68 | +3,966.42% | +258.11% | +3,708.30 | 0 Comment | |
| borcobob | 77.44 | 12/28/2009 |
|
3Y | $2.82 | +3,764.54% | +259.26% | +3,505.28 | 0 Comment | |
| royeknox | 78.02 | 8/10/2009 |
|
5Y | $3.03 | +3,496.70% | +304.66% | +3,192.04 | 0 Comment | |
| MicroOptions | 59.42 | 4/15/2010 |
|
5Y | $3.10 | +3,415.48% | +235.23% | +3,180.25 | 0 Comment | |
| MicroMikey | 81.76 | 4/15/2010 |
|
5Y | $3.10 | +3,415.48% | +235.23% | +3,180.25 | 0 Comment | |
| minifesto | 81.74 | 1/2/2009 |
|
3Y | $3.21 | +3,295.02% | +356.38% | +2,938.64 | 0 Comment | |
|
foolshand | < 20 | 7/27/2009 |
|
3W | $3.25 | +3,253.23% | +316.33% | +2,936.90 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
